Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-15

Clinical Trial Update: Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain [Phase 3]

View source ↗

Summary

Phase 3 trial investigates the morphine-sparing effect and safety of intravenous parecoxib for postoperative pain. The study, sponsored by Pfizer, has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Parecoxib (parecoxib)

Snippet

Sponsor: Pfizer | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED